ストックスクリーナーアプリを入手
1.79
16.78%
0.25
前日終値:
$1.54
開ける：
$2.15
24時間の取引高:
49.52M
Relative Volume:
22.50
時価総額：
$9.53M
収益：
$3.25M
当期純損益:
$-8.34M
株価収益率:
-0.695
EPS:
-2.5755
ネットキャッシュフロー:
$-7.71M
1週間 パフォーマンス:
+13.11%
1か月 パフォーマンス:
+19.89%
6か月 パフォーマンス:
+68.07%
1年 パフォーマンス:
-32.14%
1日の値動き範囲:
$1.69
$2.33
1週間の範囲:
$1.49
$2.33
52週間の値動き範囲:
$0.575
$2.75
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
名前
Inmed Pharmaceuticals Inc
セクター
電話
(604) 669-7207
住所
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
1.785 | 8.12M | 3.25M | -8.34M | -7.71M | -2.5755 |
TAK
Takeda Pharmaceutical Co Adr
|
16.98 | 54.45B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.885 | 44.21B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.55 | 36.10B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
74.24 | 31.95B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
529.18 | 26.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Inmed Pharmaceuticals Inc (INM) 最新ニュース
Morning Market Movers: INM, INLF, SXTC, ADVB See Big Swings - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - TradingView
InMed (NASDAQ: INM) outlines Mentari merger structure and names new CEO - Stock Titan
InMed Pharmaceuticals (INM) Gains 1.3% as Stock Approaches Key Resistance LevelForce Index - dars.gov.et
ADAR1 Capital acquires 1,000 InMed common shares worth $1,555 - Bitget
InMed Pharmaceuticals (INM) holder buys 1,000 common shares via ADAR1 - Stock Titan
Vivo Opportunity reports USD 32,319 purchase of InMed common shares - Bitget
Vivo Opportunity funds add 20,546 InMed Pharmaceuticals (INM) shares - Stock Titan
InMed Pharmaceuticals Inc (NASDAQ: INM) Share Price, INM Stock News, INM Share Price & Updates - Kalkine
InMed Pharmaceuticals(INM) Stock Options Chain | Quotes & News - Moomoo
InMed Pharmaceuticals Company Profile & Introduction - Moomoo
InMed Pharmaceuticals and Mentari Therapeutics Amend Merger Agreement and File Registration Statement for Migraine Therapy Deal 1 – Minichart - Minichart
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
InMed amends merger terms, advances Mentari transition - TipRanks
InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger - Stock Titan
InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView
InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing - Stock Titan
Enterprise value to EBIT forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView
InMed Pharmaceuticals Amends Deal With Mentari Therapeutics - Moomoo
InMed Pharmaceuticals (INM) Moves Forward with Merger Agreement Amendments - GuruFocus
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - TMX Newsfile
InMed Pharmaceuticals (INM) Stages 7% Advance: Testing Key Resistance LevelPut Dominated - DonanımHaber
InMed Pharmaceuticals และ Mentari Therapeutics ประกาศแก้ไขข้อตกลงการควบรวมกิจการ พร้อมยื่นแบบแสดงรายการข้อมูลการจดทะเบียน (Registration Statement) ตามแบบ Form S-4 - Moomoo
InMed Pharmaceuticals (INM) Slips 1.89% as Shares Test Key Support at $1.48Counter Trend Trade - dars.gov.et
INMInMed Pharmaceuticals Inc Forecast, Target Price - Finviz
Vivo Opportunity increases InMed (INM) stake with open-market share buys - Stock Titan
InMed (INM) to merge with Mentari after $290M financing; Exchange ~2.0606 - Stock Titan
InMed Pharmaceuticals (INM) Q3 2025 Earnings: Continued R&D Progress Amid No RevenueEnergy Earnings Report - DonanımHaber
Price to sales forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView
Price to earnings forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView
Enterprise value to revenue forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView
Penny stock InMed Pharmaceuticals merger deal targets migraine pipeline - MSN
InMed Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:INM) - TradingView
InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InMed Pharmaceuticals Inc. Cash Flow – DUS:MWG - TradingView
Dilution adjustment of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView
Current ratio of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView
Total revenue of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView
Basic earnings per share (basic EPS) of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView
MWG Stock Price and Chart — DUS:MWG - TradingView
InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InMed Pharmaceuticals Inc (INM) Valuation: PE, PB & Fair Value Analysis - TradingKey
InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey
InMed Pharmaceuticals Inc (INM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
InMed Pharmaceuticals Inc (INM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Moderna to Host Investor EventScience Day - Investing News Network
InMed Pharmaceuticals (INM) Slides to $1.5 as Traders Eye Support at $1.42RTH Profile - dars.gov.et
Inmed Pharmaceuticals Inc (INM) 財務データ
収益
当期純利益
現金流量
EPS
Inmed Pharmaceuticals Inc (INM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Vivo Opportunity, LLC | 10% Owner |
Jul 15 '26 |
Buy |
1.55 |
15,150 |
23,482 |
743,038 |
| Vivo Opportunity, LLC | 10% Owner |
Jul 14 '26 |
Buy |
1.55 |
5,375 |
8,331 |
729,277 |
| Vivo Opportunity, LLC | 10% Owner |
Jul 16 '26 |
Buy |
1.55 |
21 |
33 |
743,057 |
| Vivo Opportunity, LLC | 10% Owner |
Jul 01 '26 |
Buy |
1.55 |
4,344 |
6,733 |
722,935 |
| Vivo Opportunity, LLC | 10% Owner |
Jul 02 '26 |
Buy |
1.55 |
1,607 |
2,491 |
724,395 |
| Vivo Opportunity, LLC | 10% Owner |
Jun 30 '26 |
Buy |
1.54 |
600 |
924 |
718,989 |
| Vivo Opportunity, LLC | 10% Owner |
May 20 '26 |
Buy |
1.56 |
56,210 |
87,688 |
543,129 |
| Vivo Opportunity, LLC | 10% Owner |
Jun 05 '26 |
Buy |
1.57 |
55,011 |
86,367 |
688,926 |
| Vivo Opportunity, LLC | 10% Owner |
May 21 '26 |
Buy |
1.69 |
34,000 |
57,460 |
574,011 |
| Vivo Opportunity, LLC | 10% Owner |
Jun 08 '26 |
Buy |
1.52 |
32,500 |
49,400 |
718,444 |
0.58%
1.37%
大文字化:
|
ボリューム (24 時間):